Skip to content

Quest Diagnostics DGX Debt Repayments

Debt Repayments at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$0-100%
Labcorp Holdings logo
Labcorp HoldingsLH
$0-100%
Opko Health logo
Opko HealthOPK
$9.85M-48.8%
NeoGenomics logo
NeoGenomicsNEO
$50.31M
Exagen Inc. logo
Exagen Inc.XGN
$168K+57.0%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$476K+1.3%

Other financials

Income statement

See full
Revenue$3.0B+10.2%
Gross profit$1.0B+8.9%
Operating income$459.0M+4.8%
Net income$320.0M+13.5%
EPS (diluted)$2.84+15.0%

Balance sheet

See full
Cash & equivalents$626.0M+96.2%
Total debt$6.4B0.0%
Total equity$7.5B+4.0%
Total assets$16.9B+6.1%

Cash flow

See full
Operating cash flow$597.0M+9.7%
CapEx$138.0M+27.8%
Free cash flow$459.0M+5.3%

Valuation

See full
Market cap$26.04B+38.7%
Enterprise value$31.8B+28.0%
P/E24.5×+4.8×
P/S2.3×+0.5×

Profitability

See full
Gross margin33.1%+0.1pp
Operating margin14.1%+0.1pp
Net margin9.2%+0.2pp
FCF margin11.7%0.0pp

Returns & leverage

See full
Return on equity14.4%+0.7pp
Debt / equity0.8×0.0×
Current ratio1.6×+0.5×

Where this comes from

Reported directly by Quest Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfDebt.

The official record: Quest Diagnostics’s 10-Q, filed July 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Quest Diagnostics's debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Quest Diagnostics's debt repayments?
Quest Diagnostics (DGX) reported debt repayments of $500M in Q2 2026.
How has Quest Diagnostics's debt repayments changed year-over-year?
Quest Diagnostics's debt repayments increased by 24.7% year-over-year, from $401M to $500M.
What is the long-term trend for Quest Diagnostics's debt repayments?
Over 2 years (2023 to 2025), Quest Diagnostics's debt repayments has grown at a -25.9% compound annual growth rate (CAGR), from $1.84B to $1.01B.
What does debt repayments mean?
Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.